The effect of continued low dose aspirin therapy in patients undergoing percutaneous nephrolithotomy
The Journal of Urology Nov 01, 2017
Otto BJ, et al. - This research was initiated in order to determine the consequence of low-dose ASA (Aspirin) continuation through percutaneous nephrolithotomy (PCNL) and its impact on surgical and safety outcomes. It as deduced that PCNL was both effective and safe in patients continuing low dose ASA perioperatively.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
